Heavis (Cytisinicline)

Heavis is indicated for adults who wish to discontinue tobacco use and is used as part of a comprehensive smoking‑cessation program.

• As a stand‑alone pharmacologic aid for quitting smoking.
• In combination with behavioral counseling.
• For individuals who have experienced difficulty with nicotine‑replacement therapies.
• To reduce nicotine withdrawal symptoms such as irritability, anxiety, and cravings.
• May be considered when other approved cessation medications are contraindicated.

The safety profile of Heavis reflects its activity at nicotinic receptors; reported adverse events are generally mild to moderate.

Common

• Nausea
• Headache
• Dry mouth
• Insomnia
• Dizziness

Serious

• Severe allergic reaction (anaphylaxis)
• Persistent cardiovascular symptoms (e.g., palpitations, hypertension)
• Psychiatric disturbances (e.g., mood swings, depression)
• Respiratory distress
• Seizures

Clinicians should evaluate patient history and current health status before prescribing Heavis to ensure safe use.

• Assess for known hypersensitivity to cytisinicline or related compounds.
• Use caution in patients with cardiovascular disease or uncontrolled hypertension.
• Evaluate psychiatric history, especially depression or anxiety disorders.
• Consider renal or hepatic impairment, as clearance data are limited.
• Advise pregnant or breastfeeding individuals to discuss potential risks with a healthcare professional.
• Review concurrent use of other nicotine‑related products.

Heavis may interact with other medications that influence nicotinic receptors or central nervous system activity.

Avoid

• Concomitant use of other nicotinic agonists (e.g., nicotine replacement therapy, varenicline).
• Monoamine oxidase inhibitors (MAOIs) due to potential additive CNS effects.
• Strong CYP450 inhibitors if metabolic pathway identified (pending data).

Use with caution

• CNS depressants such as benzodiazepines or opioids.
• Antidepressants, particularly SSRIs, that may affect mood regulation.
• Antihypertensive agents, as blood pressure changes have been reported.